HEMO — Hemogenyx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Exercise of Warrants and Issue of Equity
Exercise of Warrants and Issue of Equity
Issue of convertible loan notes
Result of Audit Tender
Placing to Raise £250,000 and Director’s Dealing
Clearance to Proceed with Pediatric Expansion
Placing to Raise £451,250 and Director’s Dealing
Brief: Hemogenyx Pharmaceuticals Says Second Patient Treated With HG-CT-1 CAR-T Therapy Successfully Passes Initial Safety Evaluation
Second Patient Passes Initial Safety Tests
Brief: Hemogenyx Pharmaceuticals Amends Clinical Protocol For HG-CT-1
Pediatric Amendment to Clinical Protocol
AGM Correction
Placing to Raise £451,250 and Director’s Dealing
Notice of AGM
Final Results
Brief: Hemogenyx Pharmaceuticals Files Annual IND Report With FDA For HG-CT-1 Car-T Therapy For AML
FDA Annual Report
Brief: Hemogenyx Pharmaceuticals' HG-CT-1 Treatment Passes Initial Safety Assessment
Recruitment of Second Patient for Clinical Trials